Insulet Stock Buy Hold or Sell Recommendation
| PODD Stock | USD 167.25 0.02 0.01% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Insulet is 'Cautious Hold'. Macroaxis provides Insulet buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Insulet positions. The advice algorithm takes into account all of Insulet's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Insulet's buy or sell advice are summarized below:
Real Value 191.69 | Target Price 257.94 | Hype Value 166.66 | Market Value 167.25 | Naive Value 163.63 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Insulet given historical horizon and risk tolerance towards Insulet. When Macroaxis issues a 'buy' or 'sell' recommendation for Insulet, the advice is generated through an automated system that utilizes algorithms and statistical models.
Insulet |
Execute Insulet Buy or Sell Advice
The Insulet recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Insulet. Macroaxis does not own or have any residual interests in Insulet or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Insulet's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Insulet Trading Alerts and Improvement Suggestions
| Insulet generated a negative expected return over the last 90 days | |
| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: Can Higher Visits Soften Cost Blow for Teladoc in Q1 |
Insulet Returns Distribution Density
The distribution of Insulet's historical returns is an attempt to chart the uncertainty of Insulet's future price movements. The chart of the probability distribution of Insulet daily returns describes the distribution of returns around its average expected value. We use Insulet price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Insulet returns is essential to provide solid investment advice for Insulet.
| Mean Return | -0.28 | Value At Risk | -3.73 | Potential Upside | 3.20 | Standard Deviation | 2.35 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Insulet historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Insulet Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Insulet is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Insulet backward and forwards among themselves. Insulet's institutional investor refers to the entity that pools money to purchase Insulet's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Baillie Gifford & Co Limited. | 2023-12-31 | 1.2 M | Norges Bank | 2023-12-31 | 1 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1 M | D1 Capital Partners L.p. | 2023-12-31 | 1 M | William Blair Investment Management, Llc | 2023-12-31 | 918.7 K | Amvescap Plc. | 2023-12-31 | 744.6 K | Westfield Capital Management Company, Lp | 2023-12-31 | 705.4 K | Northern Trust Corp | 2023-12-31 | 666.6 K | Ameriprise Financial Inc | 2023-12-31 | 654.7 K | Capital Research Global Investors | 2023-12-31 | 9.5 M | Vanguard Group Inc | 2023-12-31 | 8 M |
Insulet Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 99.8M | 708.3M | (115.6M) | (116.7M) | 26.8M | 39.2M | |
| Free Cash Flow | (72.5M) | (82.5M) | (190.8M) | (38.3M) | 36.2M | 38.0M | |
| Depreciation | 27.9M | 55.4M | 57.4M | 63.2M | 72.8M | 76.4M | |
| Other Non Cash Items | 36.7M | 46M | 41.4M | 12.8M | (155.4M) | (147.6M) | |
| Capital Expenditures | 170.9M | 166.5M | 122.7M | 157.3M | 109.2M | 60.0M | |
| Net Income | 11.6M | 6.8M | 16.8M | 4.6M | 206.3M | 216.6M | |
| End Period Cash Flow | 213.7M | 922M | 806.4M | 689.7M | 650.7M | 683.2M | |
| Change To Inventory | (30.2M) | (50.5M) | (154.4M) | (49.1M) | (53.6M) | (50.9M) | |
| Net Borrowings | 31.2M | 128.3M | (464.9M) | (39.8M) | (35.8M) | (34.0M) | |
| Change To Netincome | 43M | 40M | 81.1M | 47.9M | 55.1M | 40.7M | |
| Investments | 97.3M | 180.5M | 40M | (7.8M) | (176.2M) | (167.4M) |
Insulet Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Insulet or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Insulet's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Insulet stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.4 | |
β | Beta against NYSE Composite | 1.39 | |
σ | Overall volatility | 2.39 | |
Ir | Information ratio | -0.16 |
Insulet Volatility Alert
Insulet exhibits very low volatility with skewness of -0.46 and kurtosis of 2.15. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Insulet's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Insulet's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Insulet Fundamentals Vs Peers
Comparing Insulet's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Insulet's direct or indirect competition across all of the common fundamentals between Insulet and the related equities. This way, we can detect undervalued stocks with similar characteristics as Insulet or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Insulet's fundamental indicators could also be used in its relative valuation, which is a method of valuing Insulet by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Insulet to competition |
| Fundamentals | Insulet | Peer Average |
| Return On Equity | 0.34 | -0.31 |
| Return On Asset | 0.0609 | -0.14 |
| Profit Margin | 0.12 % | (1.27) % |
| Operating Margin | 0.26 % | (5.51) % |
| Current Valuation | 12.24 B | 16.62 B |
| Shares Outstanding | 70.02 M | 571.82 M |
| Shares Owned By Insiders | 0.31 % | 10.09 % |
| Shares Owned By Institutions | 99.69 % | 39.21 % |
| Number Of Shares Shorted | 3.12 M | 4.71 M |
| Price To Book | 16.75 X | 9.51 X |
| Price To Sales | 7.23 X | 11.42 X |
| Revenue | 1.7 B | 9.43 B |
| Gross Profit | 805.6 M | 27.38 B |
| EBITDA | 220 M | 3.9 B |
| Net Income | 206.3 M | 570.98 M |
| Cash And Equivalents | 708.6 M | 2.7 B |
| Cash Per Share | 10.21 X | 5.01 X |
| Total Debt | 1.45 B | 5.32 B |
| Debt To Equity | 3.34 % | 48.70 % |
| Current Ratio | 4.69 X | 2.16 X |
| Book Value Per Share | 10.48 X | 1.93 K |
| Cash Flow From Operations | 145.4 M | 971.22 M |
| Short Ratio | 3.46 X | 4.00 X |
| Earnings Per Share | 2.94 X | 3.12 X |
| Price To Earnings To Growth | 3.15 X | 4.89 X |
| Target Price | 236.83 | |
| Number Of Employees | 3 K | 18.84 K |
| Beta | 1.0 | -0.15 |
| Market Capitalization | 11.71 B | 19.03 B |
| Total Asset | 2.59 B | 29.47 B |
| Retained Earnings | (378 M) | 9.33 B |
| Working Capital | 1.13 B | 1.48 B |
| Current Asset | 190.76 M | 9.34 B |
Note: Acquisition by Eric Benjamin of 4351 shares of Insulet subject to Rule 16b-3 [view details]
Insulet Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Insulet . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Insulet Buy or Sell Advice
When is the right time to buy or sell Insulet? Buying financial instruments such as Insulet Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Assets | 106.1M | 147.1M | 1.0 | 0.95 | Cash | 791.6M | 674.7M | 650.7M | 683.2M |
Use Investing Ideas to Build Portfolios
In addition to having Insulet in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Computers Thematic Idea Now
Computers
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Computers theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Computers Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Insulet Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.Note that the Insulet information on this page should be used as a complementary analysis to other Insulet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Insulet Stock analysis
When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Insulet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.043 | Earnings Share 2.94 | Revenue Per Share 24.331 | Quarterly Revenue Growth 0.379 | Return On Assets 0.0609 |
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.